Skip to main content
  • 108 Accesses

Abstract

New areas in biotechnology have progressed remarkably and are expected to produce new industries. Its methods have already been applied to a wide range of fields, such as agriculture, the chemical, food, energy and pharmaceutical industries. The key factors in biotechnology are gene manipulation, cell fusion, large-scale cell culture, and technology for bioreactors; pertinent industrial processes will require highly developed and precise equipment. The actual market scale of biotechnology has enlarged to more than 100 billion yen ($0.7 billion) in 1989 according to Nikkei Biotech (1989). Although an investigation by BIDEC (Bioindustry Development Center in the Japanese Association of Fermentation and Industry) reports that the industrial scale of biotechnology will grow up to 15,000 billion yen ($100 billion) per year by the twenty-first Century, most of the technology is now in the research and development stage. Rapid development is expected.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Borel, J. F., C. Feurer, C. Magnee, and H. Stahelin. 1977. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology 32:1017–1025.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Dreyfuss, M., E. Harii, H. Hoffman, H. Kobel, W. Pache, and H. Tscherter. 1976. Cyclosporin A and C. Eur. J. Appl. Microbiol. 3:125–133.

    Article  CAS  Google Scholar 

  • Endo, A. 1979. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J. Antibiotics 32:852–854.

    Article  CAS  Google Scholar 

  • Endo, A., M. Kuroda, and Y. Tsujita. 1976. ML-236A, ML-236B and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J. Antibiotics 29:1346–1348.

    Article  CAS  Google Scholar 

  • Fukujoji, S., M. Sugihara, H. Imai, T. Soejima, and Y. Odawara. 1987. Trends of biotechnology equipment. Hitachi Hyoron 69:289–294.

    Google Scholar 

  • Freidinger, R. M. 1989. Cholecystokinin and gastrin antagonists. Medicinal Res. Rev. 9:271–290.

    Article  CAS  Google Scholar 

  • Goetz, M. A., M. Lopez, R. L. Monaghan, R. S. L. Chang, V. J. Lotti, and T. B. Chen. 1985. Asperlicin, a novel nonpeptidal cholecystokinin antagonist from Aspergillus alliaceus. J. Antibiotics 38:1633–1637.

    Article  CAS  Google Scholar 

  • Kino, T., H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki, and H. Imanaka. 1987. FK-506, a novel immunosuppressant isolated from a streptomyces. J. Antibiotics 40:1249–1255.

    Article  CAS  Google Scholar 

  • Nikkei Biotech, ed. 1989. Nikkei Biotechnology Yearbook 89/90. Nikkei Biotech Press, Tokyo.

    Google Scholar 

  • Nukumi, M., F. Iwatani, M. Ohkuma, and Y. Odawara. 1987. Automatic colony transfer and analyzing system. Hitachi Hyoron 69:313–319.

    Google Scholar 

  • Ohkawa, T., M. Nukumi, S. Nishimura, T. Okuda, T. Furumai, and T. Honda. 1989. Instrument for the Liquid Culture. Japanese Patent Kokai H1–225476 Sept. 8, 1989.

    Google Scholar 

  • Umezawa, H., T. Aoyagi, H. Suda, M. Hamada, and T. Takeuchi. 1976. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J. Antibiotics 29:97–99.

    Article  CAS  Google Scholar 

  • Umezawa, H., T. Aoyagi, T. Hazato, K. Uotani, F. Kojima, M. Hamada, and T. Takeuchi. 1978. Esterastin, an inhibitor of esterase, produced by actinomycetes. J. Antibiotics 31:639–641.

    Article  CAS  Google Scholar 

  • Umezawa, H., T. Aoyagi, K. Uotani, M. Hamada, T. Takeuchi, and S. Takahashi. 1980. Ebelactone, an inhibitor of esterase, produced by actinomycetes. J. Antibiotics 33:1594–1596.

    Article  CAS  Google Scholar 

  • Umezawa, H., T. Aoyagi, S. Ohuchi, A. Okuyama, H. Suda, T. Takita, M. Hamada, and T. Takeuchi. 1983. Arphamenine A and B, new inhibitors of amino-peptidase B, produced by bacteria. J. Antibiotics 36:1572–1575.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Van Nostrand Reinhold

About this chapter

Cite this chapter

Okuda, T., Tabuchi, H. (1992). Automated System for Microbial Screening/Breeding. In: Bhatnagar, D., Cleveland, T.E. (eds) Molecular Approaches to Improving Food Quality and Safety. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-8070-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8070-2_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4684-8072-6

  • Online ISBN: 978-1-4684-8070-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics